VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 788 filers reported holding VANECK VECTORS ETF TR in Q2 2024. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $870 | -99.9% | 25,693 | +0.3% | 0.07% | -5.3% |
| Q1 2024 | $810,313 | +35.1% | 25,627 | +32.5% | 0.08% | +63.0% |
| Q4 2023 | $599,845 | -5.0% | 19,344 | -17.5% | 0.05% | -57.8% |
| Q3 2023 | $631,089 | +79482.5% | 23,452 | -10.9% | 0.11% | +55.7% |
| Q2 2023 | $793 | -3.6% | 26,333 | +3.6% | 0.07% | +4.5% |
| Q1 2023 | $823 | -100.0% | 25,426 | -5.6% | 0.07% | -1.5% |
| Q4 2022 | $771,837,460 | +119379.5% | 26,931 | +0.6% | 0.07% | +7.9% |
| Q3 2022 | $646,000 | -43.9% | 26,772 | -10.8% | 0.06% | -34.4% |
| Q1 2022 | $1,151,000 | +3.3% | 30,026 | -13.8% | 0.10% | +1.1% |
| Q4 2021 | $1,114,000 | +411.0% | 34,836 | +488.0% | 0.10% | +206.5% |
| Q4 2020 | $218,000 | -48.0% | 5,924 | -44.9% | 0.03% | -50.8% |
| Q3 2020 | $419,000 | -74.4% | 10,747 | -76.0% | 0.06% | -77.8% |
| Q2 2020 | $1,639,000 | -29.4% | 44,697 | -55.6% | 0.28% | -37.9% |
| Q1 2020 | $2,322,000 | -33.3% | 100,731 | -15.3% | 0.46% | -24.5% |
| Q4 2019 | $3,483,000 | +2.7% | 118,965 | -6.3% | 0.60% | -6.6% |
| Q3 2019 | $3,391,000 | +1.7% | 126,924 | -2.9% | 0.65% | +0.2% |
| Q2 2019 | $3,334,000 | +1125.7% | 130,659 | +960.6% | 0.65% | +1035.1% |
| Q1 2019 | $272,000 | +5.8% | 12,319 | +1.1% | 0.06% | -8.1% |
| Q4 2018 | $257,000 | +9.4% | 12,181 | -4.0% | 0.06% | +19.2% |
| Q3 2018 | $235,000 | +9.8% | 12,684 | +32.5% | 0.05% | +2.0% |
| Q2 2018 | $214,000 | -52.2% | 9,576 | -53.0% | 0.05% | -65.8% |
| Q1 2018 | $448,000 | -10.2% | 20,393 | -4.9% | 0.15% | -8.0% |
| Q4 2017 | $499,000 | -76.6% | 21,453 | -76.9% | 0.16% | -81.0% |
| Q3 2017 | $2,134,000 | +14.1% | 92,939 | +9.8% | 0.85% | -0.4% |
| Q2 2017 | $1,870,000 | -64.5% | 84,673 | -63.3% | 0.85% | -62.8% |
| Q1 2017 | $5,268,000 | +7.0% | 230,954 | -1.9% | 2.30% | +1.0% |
| Q4 2016 | $4,924,000 | +60.2% | 235,394 | +112.3% | 2.27% | +17.6% |
| Q2 2016 | $3,073,000 | – | 110,893 | – | 1.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,165,410 | 69.82% |
| New Harbor Financial Group, LLC | 1,523,632 | $43,667,279 | 18.06% |
| Cadence Wealth Management LLC | 617,285 | $17,691,382 | 15.17% |
| Windmill Hill Asset Management Ltd | 798,150 | $22,874,979 | 14.71% |
| Slate Path Capital LP | 8,755,000 | $250,918,300 | 13.50% |
| SPX Gestao de Recursos Ltda | 3,997,000 | $114,554,020 | 12.37% |
| New Harbor Financial Group, LLC | 704,500 | $20,190,970 | 8.35% |
| Eschler Asset Management LLP | 150,000 | $4,299,000 | 8.15% |
| Hollow Brook Wealth Management LLC | 527,007 | $15,104,021 | 7.23% |
| Yong Rong (HK) Asset Management Ltd | 400,000 | $11,464 | 7.22% |